An electrochemical sensor that can identify Parkinson's disease at various stages has been created by researchers at the Federal University of So Carlos (UFSCar) and the University of Campinas (UNICAMP) in Brazil. The gadget was created using a standard 3D printer and shown early disease det
Physical activity can improve both the quality of life and the severity of movement-related symptoms in Parkinson's disease patients. According to the preliminary Cochrane review of available research, any type of organised exercise is preferable to none.
The quality of life and the intensity of movement-related symptoms can both be enhanced by physical activity in Parkinson's disease patients. According to the initial Cochrane evaluation of the available research, any form of organised exercise is preferable than none.
An artificial blood-brain barrier model that has been constructed by researchers at Uppsala University is quick and accurate, and it may be used to assess how well antibody-based treatments can reach the brain. The new model may lessen the requirement for animal testing, which is now the mos
Many neurodegenerative illnesses, including Alzheimer's and Parkinson's, are mostly caused by tau and tubulin proteins. The accumulation of these proteins in the brain is mostly responsible for the advancement of neurodegenerative diseases.
Washington [US], October 17 (ANI): Researchers at UVA Health have identified a brain chemical that coordinates the immune system's reactions to multiple sclerosis (MS) and Alzheimer's disease, potentially enabling medical professionals to boost the body's capacity to combat these and other d
Washington [US], September 30 (ANI): Researchers have used artificial intelligence to predict hospitalisation outcomes of geriatric patients with dementia on the first or second day of admission. Early outcome assessment means more timely interventions, better care coordination, more prudent
New York [US], September 21 (ANI): According to a new study led by Weill Cornell Medicine researchers, aggregates of the protein alpha-synuclein spread in the brains of people with Parkinson's disease via a cellular waste-ejection process.
Washington DC, [USA] July 18 (ANI): Ankrd16 gene can prevent faulty proteins from causing neurological disorders like Alzheimer's and Parkinson's disease.